Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

"…<p>(A) Ki-67 expression in parathyroid glands of rats with CKD-induced sHPT treated with Cinacalcet either early in the inactive light phase (<i>Cina1</i>; N = 10) or early in the active dark phase (<i>Cina2</i>; N = 9) compared to untreated rats with sHPT investigated at similar time points (<i>PNX1</i>; N = 7 and <i>PNX2</i>; N = 7, respective) and to normal rats investigated at similar time points (<i>ctrl1</i>; N = 9 and <i>ctrl2</i>; N = 7, respective). …"

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. حسب Long Li (6555)

Differentially expressed genes (DEGs)^a showing the greatest fold changes from each potato tissue: 10 with greatest increase in expression and 10 with greatest decrease in expression. حسب Margaret A. Carpenter (6104180)

"…<p>Differentially expressed genes (DEGs)^a showing the greatest fold changes from each potato tissue: 10 with greatest increase in expression and 10 with greatest decrease in expression.…"

General procedure for the synthesis of B. حسب Xueqin lu (22250795)

General procedure for the synthesis of A and A-c1. حسب Xueqin lu (22250795)

(a) Surface area and volume change with water level; (b) Topographic changes in the Caspian Sea. حسب Zihao Duan (17403792)

(a) Change rates were calculated for each transect along the coastlines from 1985 to 2023; (b) Coastline change rates of the Caspian Sea based on the EPR and LRR. حسب Zihao Duan (17403792)

(a) M-K test of annual average water level in Caspian Sea (unformatted fit (UF) and underidentification bias (UB) is positive and reverse order in the time series respectively; ɑ i... حسب Zihao Duan (17403792)

(a) Coastline length changes in the Caspian Sea; (b) LSI changes between 1985 and 2023 (P1 = 1985–1990, P2 = 1990–1995, P3 = 1995–2000, P4 = 2000–2005, P5 = 2005–2010, P6 = 2010–20... حسب Zihao Duan (17403792)

Kylo-0603’s EC50 & tissue levels. حسب Xueqin lu (22250795)

Effects of Kylo-0603 on body weight, organ weight, and body fat content. حسب Xueqin lu (22250795)

Plasma cholesterol and LDL-C levels. حسب Xueqin lu (22250795)

Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. حسب Xueqin lu (22250795)

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. حسب Xueqin lu (22250795)

The Fibrosis scoring by Sirius Red staining and SHG/TPEF. حسب Xueqin lu (22250795)

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). حسب Xueqin lu (22250795)

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. حسب Xueqin lu (22250795)

Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... حسب Xueqin lu (22250795)

Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine... حسب Xueqin lu (22250795)

General procedure for the synthesis of Kylo-0603. حسب Xueqin lu (22250795)